HOUSTON, Sept. 22, 2020 /PRNewswire/ -- Soliton,
Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary aesthetic platform technology,
today announced that it has selected Greater Than One Group ("GTO")
as its integrated marketing agency. The collaboration will aim to
raise the visibility of the Company's Rapid Acoustic Pulse
("RAP") device and establish the Soliton brand in the aesthetic
industry through multi-channel marketing efforts.
Soliton's decision to partner with GTO comes as the Company
approaches initial U.S. commercialization of its Rapid Acoustic
Pulse device in the first half of 2021.
"We are excited to begin this relationship with GTO to enhance
Soliton's brand impression and digital presence. Greater Than One
is well-known for the imaginative aspects that the company provides
to each project, and we look forward to the creative strategy that
its team will bring to Soliton. We believe this partnership further
supports our commercialization plans for the RAP device and will
advance the Soliton brand and recognition," commented Christopher Capelli, MD, founder, President and
CEO of Soliton.
"What an amazing opportunity to be working with Soliton on this
incredible, integrated launch. GTO blends creativity, content,
media and data via closed loop technologies, and Soliton's unique
Rapid Acoustic Device for aesthetics is an exceptional breakthrough
deserving of an imaginative brand approach," said Mike Hartman, Chief Creative Officer of Greater
Than One Group.
Join our more than 200K
subscribers here to follow the
Company: https://soly-investors.com
About Greater Than One Group
Greater Than One Group is
a full-service global agency network that provides creative,
digital, media, enterprise, analytics, social media and business
consulting solutions to leading health and wellness clients around
the world. GTO utilizes converged proprietary data-driven
methodologies to provide imaginative marketing solutions in health
and wellness.
About Soliton, Inc.
Soliton, Inc. is a medical device
company with a novel and proprietary platform technology licensed
from The University of Texas on behalf
of MD Anderson Cancer Center. The Company's first FDA cleared
commercial product will use rapid pulses of acoustic shockwaves as
an accessory to lasers for the removal of unwanted tattoos. The
Company is based in Houston,
Texas, and is actively engaged in bringing the Rapid
Acoustic Pulse ("RAP") device to the market. The Company believes
this "Soliton" method has the potential to lower tattoo removal
costs for patients, while increasing profitability to
practitioners, compared to current laser removal methods.
Soliton has completed a clinical study using the RAP device to
improve the appearance of cellulite and is investigating potential
additional capabilities of the RAP technology. The device is
currently cleared in the United
States only for use in tattoo removal and is not yet cleared
for use to address cellulite.
For more information about the Company, please
visit: http://www.soliton.com
Forward-Looking Statements
This press release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act
of 1934 and the Private Securities Litigation Reform Act of 1995,
which statements involve risks and uncertainties. Forward-looking
statements in this press release include, without limitation, our
ability to successfully launch our product in the first half of
2021. These statements relate to future events, future
expectations, plans and prospects. Although Soliton believes that
the expectations reflected in such forward-looking statements are
reasonable as of the date made, actual results or outcomes may
prove to be materially different from the expectations expressed or
implied by such forward-looking statements. Soliton has attempted
to identify forward-looking statements by terminology including
''believes,'' ''estimates,'' ''anticipates,'' ''expects,''
''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,''
''could,'' ''might,'' ''will,'' "would," ''should,''
''approximately'' or other words that convey uncertainty of future
events or outcomes to identify these forward-looking statements.
These statements are only predictions and involve known and unknown
risks, uncertainties, and other factors, including those discussed
in our filings with the Securities and Exchange Commission ("SEC"),
including under the heading " Risk Factors" in the Form 10-K for
year ended December 31, 2019 filed
with the SEC and as updated in our Form 10-Q filings and in our
other filings with the SEC. Any forward-looking statements
contained in this release speak only as of its date. Soliton
undertakes no obligation to update any forward-looking statements
contained in this release to reflect events or circumstances
occurring after its date or to reflect the occurrence of
unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-appoints-greater-than-one-group-as-its-integrated-marketing-agency-301134988.html
SOURCE Soliton, Inc.